These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32775300)

  • 21. [Effects of anti-PD-L1 monoclonal antibody and EGFR-TKI on the expression of PD-L1 and function of T lymphocytes in EGFR-mutated lung cancer cells].
    She Y; Pan X; Xing YF; Zhou T; Zhang ZL; Shi MH; Chen YJ
    Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):886-892. PubMed ID: 27998463
    [No Abstract]   [Full Text] [Related]  

  • 22. MiR-940 promotes the proliferation and migration of gastric cancer cells through up-regulation of programmed death ligand-1 expression.
    Fan Y; Che X; Hou K; Zhang M; Wen T; Qu X; Liu Y
    Exp Cell Res; 2018 Dec; 373(1-2):180-187. PubMed ID: 30367831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-873/PD-L1 axis regulates the stemness of breast cancer cells.
    Gao L; Guo Q; Li X; Yang X; Ni H; Wang T; Zhao Q; Liu H; Xing Y; Xi T; Zheng L
    EBioMedicine; 2019 Mar; 41():395-407. PubMed ID: 30803931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A bispecific fusion protein and a bifunctional enediyne-energized fusion protein consisting of TRAIL, EGFR peptide ligand, and apoprotein of lidamycin against EGFR and DR4/5 show potent antitumor activity.
    Zhu D; Wang X; Shang Y; Li Y; Jiang W; Li L; Chen SZ
    Anticancer Drugs; 2015 Jan; 26(1):64-73. PubMed ID: 25122444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human gastric cancer cells through downregulating JNK-mediated cytoprotective autophagy.
    Xu Y; Wang Q; Zhang L; Zheng M
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):555-564. PubMed ID: 29383484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-200a enhances TRAIL-induced apoptosis in gastric cancer cells by targeting A20.
    Guo T; Zhang Y; Qu X; Che X; Li C; Fan Y; Wan X; Ma R; Hou K; Zhou H; He X; Hu X; Liu Y; Xu L
    Cell Biol Int; 2018 May; 42(5):506-514. PubMed ID: 29274253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. JWA regulates TRAIL-induced apoptosis via MARCH8-mediated DR4 ubiquitination in cisplatin-resistant gastric cancer cells.
    Wang Q; Chen Q; Zhu L; Chen M; Xu W; Panday S; Wang Z; Li A; Røe OD; Chen R; Wang S; Zhang R; Zhou J
    Oncogenesis; 2017 Jul; 6(7):e353. PubMed ID: 28671676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased EGFR Phosphorylation Correlates with Higher Programmed Death Ligand-1 Expression: Analysis of TKI-Resistant Lung Cancer Cell Lines.
    Suda K; Rozeboom L; Furugaki K; Yu H; Melnick MAC; Ellison K; Rivard CJ; Politi K; Mitsudomi T; Hirsch FR
    Biomed Res Int; 2017; 2017():7694202. PubMed ID: 29119113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis.
    Bhere D; Tamura K; Wakimoto H; Choi SH; Purow B; Debatisse J; Shah K
    Neuro Oncol; 2018 Jan; 20(2):215-224. PubMed ID: 29016934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p.
    Audrito V; Serra S; Stingi A; Orso F; Gaudino F; Bologna C; Neri F; Garaffo G; Nassini R; Baroni G; Rulli E; Massi D; Oliviero S; Piva R; Taverna D; Mandalà M; Deaglio S
    Oncotarget; 2017 Feb; 8(9):15894-15911. PubMed ID: 28199980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein Expression of Programmed Death 1 Ligand 1 and HER2 in Gastric Carcinoma.
    Oki E; Okano S; Saeki H; Umemoto Y; Teraishi K; Nakaji Y; Ando K; Zaitsu Y; Yamashita N; Sugiyama M; Nakashima Y; Ohgaki K; Oda Y; Maehara Y
    Oncology; 2017; 93(6):387-394. PubMed ID: 28910818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p.
    Zhou WY; Zhang MM; Liu C; Kang Y; Wang JO; Yang XH
    J Cell Physiol; 2019 Dec; 234(12):23176-23189. PubMed ID: 31206665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor necrosis factor-related apoptosis-inducing ligand induces the expression of proinflammatory cytokines in macrophages and re-educates tumor-associated macrophages to an antitumor phenotype.
    Gao J; Wang D; Liu D; Liu M; Ge Y; Jiang M; Liu Y; Zheng D
    Mol Biol Cell; 2015 Sep; 26(18):3178-89. PubMed ID: 26224317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-106b inhibitors sensitize TRAIL-induced apoptosis in hepatocellular carcinoma through increase of death receptor 4.
    Xu C; Shi L; Chen W; Fang P; Li J; Jin L; Pan Z; Pan C
    Oncotarget; 2017 Jun; 8(26):41921-41931. PubMed ID: 28410209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-128 Targets the SIRT1/ROS/DR5 Pathway to Sensitize Colorectal Cancer to TRAIL-Induced Apoptosis.
    Lian B; Yang D; Liu Y; Shi G; Li J; Yan X; Jin K; Liu X; Zhao J; Shang W; Zhang R
    Cell Physiol Biochem; 2018; 49(6):2151-2162. PubMed ID: 30257253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
    Yoshida T; Zhang Y; Rivera Rosado LA; Zhang B
    Mol Cancer Res; 2009 Nov; 7(11):1835-44. PubMed ID: 19843632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression.
    Napolitano S; Matrone N; Muddassir AL; Martini G; Sorokin A; De Falco V; Giunta EF; Ciardiello D; Martinelli E; Belli V; Furia M; Kopetz S; Morgillo F; Ciardiello F; Troiani T
    J Exp Clin Cancer Res; 2019 Dec; 38(1):492. PubMed ID: 31842958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
    Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
    Biochem Pharmacol; 2009 Apr; 77(8):1328-36. PubMed ID: 19426671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal growth factor induces STAT1 expression to exacerbate the IFNr-mediated PD-L1 axis in epidermal growth factor receptor-positive cancers.
    Cheng CC; Lin HC; Tsai KJ; Chiang YW; Lim KH; Chen CG; Su YW; Peng CL; Ho AS; Huang L; Chang YC; Lin HC; Chang J; Chang YF
    Mol Carcinog; 2018 Nov; 57(11):1588-1598. PubMed ID: 30035369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma.
    Su L; Guo W; Lou L; Nie S; Zhang Q; Liu Y; Chang Y; Zhang X; Li Y; Shen H
    Mol Carcinog; 2020 May; 59(5):520-532. PubMed ID: 32134157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.